Synthesis of a novel prodrug of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans-propenoic acid for colon delivery

Bioorg Med Chem Lett. 2005 Nov 15;15(22):5049-52. doi: 10.1016/j.bmcl.2005.07.088.

Abstract

A novel high-yielding and environment-friendly synthesis of the anticancer compound 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans-propenoic acid is described. This compound was conjugated to H2N-Ala-Pro dipeptide to give a prodrug to be activated by intestinal ACE and to be used in the treatment of different forms of colon cancer. Data on the chemical and enzymatic stability of this novel prodrug are reported.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colon / drug effects
  • Colon / metabolism*
  • Diterpenes / chemical synthesis*
  • Diterpenes / chemistry
  • Diterpenes / pharmacology*
  • Molecular Structure
  • Prodrugs / administration & dosage*
  • Prodrugs / chemical synthesis*
  • Prodrugs / chemistry
  • Prodrugs / pharmacology
  • Propionates / chemical synthesis*
  • Propionates / chemistry
  • Propionates / pharmacology*

Substances

  • 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans-propenoic acid
  • Diterpenes
  • Prodrugs
  • Propionates